enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Atopic dermatitis - Wikipedia

   en.wikipedia.org/wiki/Atopic_dermatitis

   Atopic dermatitis (AD), also known as atopic eczema, is a long-term type of inflammation of the skin. [2] Atopic dermatitis is also often called simply eczema but the same term is also used to refer to dermatitis, the larger group of skin conditions. [2] [5] Atopic dermatitis results in itchy, red, swollen, and cracked skin. [2]

3. Id reaction - Wikipedia

   en.wikipedia.org/wiki/Id_reaction

   Stasis dermatitis, allergic contact dermatitis, acute irritant contact eczema and infective dermatitis have been documented as possible triggers, but the exact cause and mechanism is not fully understood. [7] Several other types of id reactions exist including erythema nodosum, erythema multiforme, Sweet's syndrome and urticaria. [3]

4. Dermatitis - Wikipedia

   en.wikipedia.org/wiki/Dermatitis

   The term atopic dermatitis was coined in 1933 by Wise and Sulzberger. [95] Sulfur as a topical treatment for eczema was fashionable in the Victorian and Edwardian eras. [84] The word dermatitis is from the Greek δέρμα derma 'skin' and -ῖτις-itis 'inflammation' and eczema is from Greek: ἔκζεμα ekzema 'eruption'. [96]

5. Erythema annulare centrifugum - Wikipedia

   en.wikipedia.org/wiki/Erythema_annulare_centrifugum

   A skin biopsy can be performed to test for EAC; tests should be performed to rule out other possible diseases such as: pityriasis rosea, tinea corporis, psoriasis, nummular eczema, atopic dermatitis, drug reaction, erythema migrans and other rashes.

6. Abrocitinib - Wikipedia

   en.wikipedia.org/wiki/Abrocitinib

   In the EU, abrocitinib is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy. [9]In the US, abrocitinib is indicated for the treatment of people twelve years of age and older with refractory, moderate-to-severe atopic dermatitis whose disease is not adequately controlled with other systemic drug products, including biologics ...

7. Eczema Area and Severity Index - Wikipedia

   en.wikipedia.org/wiki/Eczema_Area_and_Severity_Index

   The Eczema Area and Severity Index (EASI) is a validated tool for the measurement of severity of atopic dermatitis.It ranges from 0 (no disease) to 72 (maximal disease). [1] [2] The EASI was developed in 1998 by modifying the Psoriasis Area and Severity Index (PASI), a widely accepted scoring system for psoriasis.